相关实验视频
Updated: Apr 3, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
6.2K
一个小分子将乌比基酶从一个渐进式转换为一个分布式酶机制
Stefan G Kathman1, Ingrid Span1, Aaron T Smith1
1Center for Molecular Innovation and Drug Discovery, Chemistry of Life Processes Institute, Department of Chemistry, Department of Molecular Biosciences, Northwestern University , Silverman Hall, 2145 Sheridan Road, Evanston, Illinois 60208, United States.
Journal of the American Chemical Society
|September 16, 2015
概括
研究人员发现,通过突变或小分子破坏E3连接酶Nedd4-1的过程性,会改变其机制. 这一发现揭示了针对各种疾病开发向E3酶抑制剂的新策略.
科学领域:
- 生物化学
- 分子生物学
- 酵素学
背景情况:
- 在许多人类疾病中,E3链酶至关重要,但它们的机制仍然不完全理解.
- 需要大量的药理工具来研究E3连接酶的功能.
研究的目的:
- 研究 HECT E3 连接酶 Nedd4-1 的酶机制.
- 发现和描述Nedd4-1的抑制剂.
- 探索过程性干扰对Nedd4-1活动的影响.
主要方法:
- 生物化学测试以研究酶的过程性.
- 用X射线结晶学来确定抑制剂的结合方式.
- 酶动力学和结构生物学技术.
主要成果:
- Nedd4-1被确定为一个过程性酶.
- 通过突变或小分子破坏Nedd4-1的过程性将其机制转移到分布式聚基因链合成.
- 首个对Nedd4-1的共价抑制剂被发现并具有结构特征,也诱导了转向分布机制.
- 渐进性Nedd4-1与其分布式抑制剂结合形式不同,在USP8的存在下合成了多基链.
结论:
- 抑制E3酶过程性是开发新型E3抑制剂的有希望的策略.
- 这项研究提供了对HECT E3酶机制的基本见解.
- 发现了一种针对Nedd4-1的新型HECT E3抑制剂.
相关概念视频
The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome
10.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.6K
The Proteasome
5.1K
5.1K
Regulated Protein Degradation
9.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Intralumenal Vesicles and Multivesicular Bodies
5.2K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
5.2K
Export of Misfolded Proteins out of the ER
5.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K

